Original Article

Breast Cancer in Mississippi: Impact of Race and Residential Geographical Setting on Cancer at Initial Diagnosis

Authors: Kathleen Mechelle Keeton, PhD, Ellen S. Jones, PhD, Sunit Sebastian, MD

Abstract

Objective: To analyze female breast cancer data for Mississippi from 2005 to 2009 to test whether race and/or geography had an impact on the stage of breast cancer at the time of diagnosis.

Methods: A cross-sectional design for data was developed and collected by the Mississippi Cancer Registry (MCR). The MCR dataset contained female breast cancer cases diagnosed between 2005 and 2009. Of the 9699 cases used, 2925 were white patients living in urban counties and 3584 were white patients residing in a rural county. Among African American patients, 1247 lived in urban areas, and 1943 resided in rural counties.

Results: Geography had a significant impact on the stage of breast cancer at which the patient was diagnosed. Women living in rural Mississippi had a greater chance (white 4% and African American 19%) of presenting with advanced regional/distant breast cancer rather than in situ/localized breast cancer. The number of white patients was similar to the number of African American patients who presented at the time of diagnosis with advanced regional/distant breast cancer. African American women had greater odds than white women (urban 25%, rural 47%) of presenting with advanced regional/distant breast cancer.

Conclusions: This study provides important new information about two specific factors that may affect the stage of breast cancer diagnosis: race (whites vs African Americans) and geography (urban vs rural county). The implications of this study will aid the Mississippi State Department of Health in targeting screening programs throughout the state. The results also may affect medical and allied health care.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. National Cancer Institute. Surveillance, Epidemiology and End Results. SEER cancer statistics review, 1975-2006. http://seer.cancer.gov/archive/csr/1975_2006/. Accessed April 2, 2013.
 
2. Moore FD, Woodrow SI, Aliapoilios MA, et al. Carcinoma of the breast. A decade of new results with old concepts. N Engl J Med 1967;277:343-350.
 
3. Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program (NBCCEDP). http://www.cdc.gov/cancer/nbccedp. Accessed April 22, 2013.
 
4. Plescia M, Richardson LC, Joseph D. New roles for public health in cancer screening. CA Cancer J Clin 2012;62:217-219.
 
5. Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences, 9th ed, Hoboken, NJ: John Wiley & Sons, 2009.
 
6. McDougall JA, Li CI. Trends in distant-stage breast cancer, colorectal, and prostate cancer incidence rates from 1992 to 2004: potential influences of screening and hormonal factors. Horm Cancer 2010;1:55-62.
 
7. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 2007;9:R28.
 
8. Adams SA, Butler WM, Fulton J, et al. Racial disparities in breast cancer mortality in a multiethnic cohort in the Southeast. Cancer 2012;118: 2693-2699.
 
9. Wan N, Zhan FB, Cai Z. Socioeconomic disparities in prostate cancer mortality and the impact of geographic scale. South Med J 2011;104:553-559.